<?xml version="1.0" encoding="UTF-8"?>

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="hiv-c-de72"/>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="CodeSystem-concept-codes.html"><code>http://fhir.org/guides/itech-uw/who-smart-hiv-dak/CodeSystem/concept-codes</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE72">HIV.C.DE72</a></td><td>Dolutegravir (DTG)</td><td>Third-drug for PEP in adults and adolescents - Dolutegravir (DTG)</td></tr><tr><td><a href="CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE73">HIV.C.DE73</a></td><td>Raltegravir (RAL)</td><td>Third-drug for PEP in adults and adolescents - Raltegravir (RAL)</td></tr><tr><td><a href="CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE74">HIV.C.DE74</a></td><td>Darunavir/ritonavir (DRV/r)</td><td>Third-drug for PEP in adults and adolescents - Darunavir/ritonavir (DRV/r)</td></tr><tr><td><a href="CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE75">HIV.C.DE75</a></td><td>Atazanavir/ritonavir (ATV/r)</td><td>Third-drug for PEP in adults and adolescents - Atazanavir/ritonavir (ATV/r)</td></tr><tr><td><a href="CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE76">HIV.C.DE76</a></td><td>Lopinavir/ritonavir (LPV/r)</td><td>Third-drug for PEP in adults and adolescents - Lopinavir/ritonavir (LPV/r)</td></tr></table></li></ul></div>
  </text>
  <url value="http://fhir.org/guides/itech-uw/ValueSet/hiv-c-de72"/>
  <version value="0.3.0"/>
  <name value="ThirddrugforPEPinadultsandadolescentsCodes"/>
  <title value="Third-drug for PEP in adults and adolescents Codes"/>
  <status value="draft"/>
  <experimental value="false"/>
  <date value="2024-03-05T14:51:57+00:00"/>
  <publisher value="World Health Organization (WHO) "/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="https://www.who.int"/>
    </telecom>
  </contact>
  <description value="Codes representing possible values for the Third-drug for PEP in adults and adolescents element"/>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="001"/>
    </coding>
  </jurisdiction>
  <immutable value="true"/>
  <compose>
    <include>
      <system value="http://fhir.org/guides/itech-uw/who-smart-hiv-dak/CodeSystem/concept-codes"/>
      <concept>
        <code value="HIV.C.DE72"/>
        <display value="Dolutegravir (DTG)"/>
      </concept>
      <concept>
        <code value="HIV.C.DE73"/>
        <display value="Raltegravir (RAL)"/>
      </concept>
      <concept>
        <code value="HIV.C.DE74"/>
        <display value="Darunavir/ritonavir (DRV/r)"/>
      </concept>
      <concept>
        <code value="HIV.C.DE75"/>
        <display value="Atazanavir/ritonavir (ATV/r)"/>
      </concept>
      <concept>
        <code value="HIV.C.DE76"/>
        <display value="Lopinavir/ritonavir (LPV/r)"/>
      </concept>
    </include>
  </compose>
</ValueSet>